- Home
- VFS vs BPMC Comparison
VFS vs BPMC Comparison
Compare VFS & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VFS
- BPMC
- Stock Information
- Founded
- VFS 2017
- BPMC 2008
- Country
- VFS Vietnam
- BPMC United States
- Employees
- VFS N/A
- BPMC N/A
- Industry
- VFS Blank Checks
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- VFS Finance
- BPMC Health Care
- Exchange
- VFS Nasdaq
- BPMC Nasdaq
- Market Cap
- VFS 8.2B
- BPMC 8.3B
- IPO Year
- VFS N/A
- BPMC 2015
- Fundamental
- Price
- VFS $3.53
- BPMC $128.42
- Analyst Decision
- VFS Buy
- BPMC Buy
- Analyst Count
- VFS 3
- BPMC 20
- Target Price
- VFS $5.75
- BPMC $127.82
- AVG Volume (30 Days)
- VFS 619.1K
- BPMC 3.5M
- Earning Date
- VFS 06-09-2025
- BPMC 07-31-2025
- Dividend Yield
- VFS N/A
- BPMC N/A
- EPS Growth
- VFS N/A
- BPMC N/A
- EPS
- VFS N/A
- BPMC N/A
- Revenue
- VFS $2,103,991,902.00
- BPMC $562,121,000.00
- Revenue This Year
- VFS N/A
- BPMC $44.46
- Revenue Next Year
- VFS $40.04
- BPMC $32.78
- P/E Ratio
- VFS N/A
- BPMC N/A
- Revenue Growth
- VFS 65.72
- BPMC 99.19
- 52 Week Low
- VFS $2.56
- BPMC $73.04
- 52 Week High
- VFS $5.38
- BPMC $128.75
- Technical
- Relative Strength Index (RSI)
- VFS 50.29
- BPMC 74.76
- Support Level
- VFS $3.46
- BPMC $128.06
- Resistance Level
- VFS $3.75
- BPMC $128.78
- Average True Range (ATR)
- VFS 0.12
- BPMC 0.26
- MACD
- VFS -0.00
- BPMC -1.13
- Stochastic Oscillator
- VFS 46.34
- BPMC 53.85
About VFS VinFast Auto Ltd.
VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is developing medicines in the following focus areas; allergy, inflammation, oncology, and hematology. Its approved medicines, including Avyakit and Avyakyt, are given to patients living with systemic mastocytosis (SM) and PDGFRA Exon 18 mutant GIST in the U.S. and Europe. The company also has various other drug candidates in its pipeline such as BLU-808, BLU-222, BLU-956, and others that are being developed to treat mast cell diseases including SM and chronic urticaria, breast cancer, and other solid tumors. Geographically, it operates in the United States, which is its key revenue market, and Europe.